Instil Bio, Inc.
TIL
$7.95
-$0.03-0.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.35M | 6.06M | 5.90M | 6.16M | 9.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.02M | 9.56M | 15.02M | 12.90M | 14.48M |
| Operating Income | -6.02M | -9.56M | -15.02M | -12.90M | -14.48M |
| Income Before Tax | -4.20M | -8.19M | -13.59M | -21.39M | -28.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.20M | -8.19M | -13.59M | -21.39M | -28.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.20M | -8.19M | -13.59M | -21.39M | -28.20M |
| EBIT | -6.02M | -9.56M | -15.02M | -12.90M | -14.48M |
| EBITDA | -6.01M | -9.55M | -15.01M | -12.89M | -13.98M |
| EPS Basic | -0.62 | -1.21 | -2.01 | -3.24 | -4.32 |
| Normalized Basic EPS | -0.45 | -0.75 | -1.26 | -1.03 | -1.16 |
| EPS Diluted | -0.62 | -1.21 | -2.01 | -3.24 | -4.32 |
| Normalized Diluted EPS | -0.45 | -0.75 | -1.26 | -1.03 | -1.16 |
| Average Basic Shares Outstanding | 6.78M | 6.78M | 6.76M | 6.60M | 6.53M |
| Average Diluted Shares Outstanding | 6.78M | 6.78M | 6.76M | 6.60M | 6.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |